Business Context and Reporting Period
This Form 8-K is filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on August 11, 2011, reporting events occurring on August 10, 2011. The filing serves to announce the Company's financial results for the three and six-month periods ended June 30, 2011, via a press release attached as Exhibit 99.01.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the referenced press release (Exhibit 99.01) and are not explicitly stated in the body of this 8-K document.
Material Changes
The filing does not detail specific material changes versus prior periods within the text provided. It solely references the issuance of the press release containing the comparative financial results.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risks, or contingencies are not detailed in the text of this 8-K. The document incorporates the press release by reference for such information but includes standard disclaimers that the information is not deemed "filed" under Section 18 of the Exchange Act for liability purposes.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) in the attached Exhibit 99.01 press release.
- Confirm the discrepancy between the requested company name (Palisade Bio, Inc.) and the actual registrant (Neuralstem, Inc.).
- Review the full text of the press release for any guidance or operational updates not summarized in this 8-K.